Intended for healthcare professionals

Latest dermatology news


Nivolumab plus ipilimumab demonstrates ‘durable improvement in survival’ for melanoma patients

Median overall survival (OS) for patients with advanced melanoma was 72.1 months when they received nivolumab in combination with ipilimumab.

11 Jun 2021

Secukinumab approved to treat paediatric plaque psoriasis in the US

IL-17A inhibitor has been cleared in the US to treat plaque psoriasis in certain patients aged six years and older

07 Jun 2021

Gene expression analysis may improve stage III melanoma patient management

Predictive biomarkers could be used to personalise treatment for patients 


19 May 2021

Skin therapist to raise money for BSF with Sahara trek

Skin therapist takes on a five-day trek across the Sahara Dessert with the hope of raising £2,500 for the British Skin Foundation. 

19 May 2021

Intermittent fasting shows promise for psoriasis skin symtoms

Study participants reported improvements in scaling, thickness and itching 

18 May 2021

EADV moves to unify objectives on skin cancer prevention across Europe

The Academy has held a roundtable discussion to assess the effectiveness of the European Commission’s Beating Cancer Plan and identify joint recommendations on preventing skin cancer and melanoma

18 May 2021

Sonelokimab shows promise for psoriasis in Phase II trial

Data published in The Lancet show that the Trispecific Nanobody “totally clears skin in almost 6 out of 10 patients” with moderate to severe psoriasis

18 May 2021

Deucravacitinib shows superiority over apremilast in late-stage psoriasis trials

The investigational selective tyrosine kinase 2 (TYK2) inhibitor deucravacitinib showed superiority over apremilast in two Phase III psoriasis trials.

14 May 2021

Skin cancer diagnoses dropped 28% between April and November 2020

British Association of Dermatologists urges public to check for signs of skin cancer following ‘concerning’ decrease

10 May 2021